Autopsy report · NCT00131872
Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts
Cause of deathNo reason given
Life of this trial
- Registered 1 year 5 months after it had already started.
- Ran for about 2 years 8 months before it stopped.
- 172 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- LeMaitre Vascular
- Sponsor type
- Industry
- Conditions
- End Stage Renal Disease
- Interventions
- Expedial Vascular Access Graft
- Participants
- 172 (planned, not actual)
- Sites
- 8
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.